Li Shuguang, Sun Shijun, Yang Chentao, Chen Hongbin, Yin Yuyao, Li Henan, Zhao Chunjiang, Wang Hui
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Department of Pharmacology, Xingtai Medical College, Xingtai, China.
Front Microbiol. 2018 Feb 27;9:332. doi: 10.3389/fmicb.2018.00332. eCollection 2018.
To investigate the epidemiology and genetic structure of bacteremia in China, a total of 416 isolates from 22 teaching hospitals in 12 cities from 2013 and 2016 were characterized by antibiogram analysis, multilocus sequence typing (MLST), typing and staphylococcal cassette chromosome (SCC) typing. The predominant meticillin-susceptible (MSSA) genotypes in 2013 were ST188 (19.1%), ST7 (8.7%), and ST398 (7.8%), respectively, and they continued to be the main genotypes in 2016. The prevalence of meticillin-resistant (MRSA) were 36.5% (66/181) and 36.6% (86/235) in 2013 and 2016, respectively. Interestingly, the susceptibility rates of MRSA to rifampicin and fluoroquinolones increased significantly from 2013 to 2016 ( < 0.01), and this was associated with changes in genetic structure. ST239-t030-MRSA, the predominant genotype among all MRSAs in 2013 (34.8%), was replaced by ST59-t437-MRSA (15.1%) in 2016. Further analysis revealed that the ST239-t030-MRSA were more resistant to rifampicin, tetracycline and fluoroquinolones than ST59-t437-MRSA ( < 0.01). To further gain insight into the mechanisms underlying the changes of genetic structure, competition and fitness measurements were performed. Importantly, ST239-t030-MRSA displayed lower growth rate and lower competitive advantage compared to ST59-t437-MRSA. Together, our findings reveal that fitness advantage of ST59-t437-MRSA over ST239-t030-MRSA may lead to changes in genetic structure and increased susceptibility of MRSA to rifampicin and fluoroquinolones in Chinese patients with bacteremia. Our study supports temporal dynamics in MRSA clone diversities, further providing critical insights into the importance of continued monitoring of MRSA.
为调查中国菌血症的流行病学和遗传结构,对2013年至2016年来自12个城市22家教学医院的416株分离菌进行了抗菌谱分析、多位点序列分型(MLST)、分型及葡萄球菌盒式染色体(SCC)分型。2013年主要的甲氧西林敏感(MSSA)基因型分别为ST188(19.1%)、ST7(8.7%)和ST398(7.8%),2016年它们仍是主要基因型。2013年和2016年耐甲氧西林金黄色葡萄球菌(MRSA)的患病率分别为36.5%(66/181)和36.6%(86/235)。有趣的是,2013年至2016年MRSA对利福平及氟喹诺酮类药物的敏感率显著增加(<0.01),这与遗传结构的变化有关。2013年所有MRSA中占主导地位的基因型ST239-t030-MRSA(34.8%)在2016年被ST59-t437-MRSA(15.1%)取代。进一步分析显示,ST239-t030-MRSA比利福平、四环素及氟喹诺酮类药物更耐药(<0.01)。为进一步深入了解遗传结构变化的潜在机制,进行了竞争和适应性测量。重要的是,与ST59-t437-MRSA相比,ST239-t030-MRSA显示出较低的生长速率和较低的竞争优势。总之,我们的研究结果表明,在中国菌血症患者中,ST59-t437-MRSA相对于ST239-t030-MRSA的适应性优势可能导致遗传结构变化及MRSA对利福平及氟喹诺酮类药物的敏感性增加。我们的研究支持了MRSA克隆多样性的时间动态变化,进一步为持续监测MRSA的重要性提供了关键见解。